Selected publications
-
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Nature Communications.
2016
Academic Article
GET IT
Times cited: 24 -
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Breast Cancer Research.
2015
Academic Article
GET IT
Times cited: 13 -
Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers.
Cancer Epidemiology Biomarkers and Prevention.
2015
Academic Article
GET IT
Times cited: 14 -
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
PLoS Genetics.
2013
Academic Article
GET IT
Times cited: 169 -
Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk.
PLoS Genetics.
2013
Academic Article
GET IT
Times cited: 75 -
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Human Genetics.
2011
Academic Article
GET IT
Times cited: 12 -
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute.
2011
Academic Article
GET IT
Times cited: 31 -
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction.
Cancer Research.
2010
Academic Article
GET IT
Times cited: 133